These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 1732059)

  • 1. Measurement of thymidine replacement in patients with high grade gliomas, head and neck tumors, and high grade sarcomas after continuous intravenous infusions of 5-iododeoxyuridine.
    Cook JA; Glass J; Lebovics R; Bobo H; Pass H; DeLaney TF; Oldfield EH; Mitchell JB; Glatstein E; Goffman TE
    Cancer Res; 1992 Feb; 52(3):719-25. PubMed ID: 1732059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of locally advanced cancer of the head and neck with 5'-iododeoxyuridine and hyperfractionated radiation therapy: measurement of cell labeling and thymidine replacement.
    Epstein AH; Lebovics RS; Goffman T; Teague D; Fuetsch ES; Glatstein E; Okunieff P; Cook JA
    J Natl Cancer Inst; 1994 Dec; 86(23):1775-80. PubMed ID: 7966416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetics of cell labeling and thymidine replacement after continuous infusion of halogenated pyrimidines in vivo.
    Rodriguez R; Ritter MA; Fowler JF; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):105-13. PubMed ID: 8175417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I trial of intraperitoneal iododeoxyuridine with and without intravenous high-dose folinic acid in the treatment of advanced malignancies primarily confined to the peritoneal cavity: flow cytometric and pharmacokinetic analysis.
    Morgan RJ; Newman EM; Doroshow JH; McGonigle K; Margolin K; Raschko J; Chow W; Somlo G; Leong L; Tetef M; Shibata S; Hamasaki V; Carroll M; Vasilev S; Akman S; Coluzzi P; Wagman L; Longmate J; Paz B; Yen Y; Klevecz R
    Cancer Res; 1998 Jul; 58(13):2793-800. PubMed ID: 9661893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative radiation therapy and iododeoxyuridine for large retroperitoneal sarcomas.
    Robertson JM; Sondak VK; Weiss SA; Sussman JJ; Chang AE; Lawrence TS
    Int J Radiat Oncol Biol Phys; 1995 Jan; 31(1):87-92. PubMed ID: 7995772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell kinetics of head and neck cancers.
    Kotelnikov VM; Coon JS IV; Haleem A; Taylor S IV; Hutchinson J; Panje W; Caldarelli DD; Griem K; Preisler HD
    Clin Cancer Res; 1995 May; 1(5):527-37. PubMed ID: 9816012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The potential superiority of bromodeoxyuridine to iododeoxyuridine as a radiation sensitizer in the treatment of colorectal cancer.
    Lawrence TS; Davis MA; Maybaum J; Mukhopadhyay SK; Stetson PL; Normolle DP; McKeever PE; Ensminger WD
    Cancer Res; 1992 Jul; 52(13):3698-704. PubMed ID: 1617642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leucovorin modulation of 5-iododeoxyuridine radiosensitization: a phase I study.
    McGinn CJ; Kunugi KA; Tutsch KD; Feierabend C; Alberti D; Lindstrom MJ; Wilding G; Arzoomanian RZ; Kinsella TJ
    Clin Cancer Res; 1996 Aug; 2(8):1299-305. PubMed ID: 9816300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorodeoxyuridine-mediated modulation of iododeoxyuridine incorporation and radiosensitization in human colon cancer cells in vitro and in vivo.
    Lawrence TS; Davis MA; McKeever PE; Maybaum J; Stetson PL; Normolle DP; Ensminger WD
    Cancer Res; 1991 Aug; 51(15):3900-5. PubMed ID: 1830239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell proliferation kinetics in human tumor xenografts measured with iododeoxyuridine labeling and flow cytometry: a study of heterogeneity and a comparison between different methods of calculation and other proliferation measurements.
    Perez LA; Dombkowski D; Efird J; Preffer F; Suit HD
    Cancer Res; 1995 Jan; 55(2):392-8. PubMed ID: 7812972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of leucovorin on idoxuridine cytotoxicity and DNA incorporation.
    Greene RF; Collins JM
    Cancer Res; 1990 Oct; 50(20):6652-6. PubMed ID: 2208128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective radiosensitization of drug-resistant MutS homologue-2 (MSH2) mismatch repair-deficient cells by halogenated thymidine (dThd) analogues: Msh2 mediates dThd analogue DNA levels and the differential cytotoxicity and cell cycle effects of the dThd analogues and 6-thioguanine.
    Berry SE; Davis TW; Schupp JE; Hwang HS; de Wind N; Kinsella TJ
    Cancer Res; 2000 Oct; 60(20):5773-80. PubMed ID: 11059773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iododeoxyuridine (IdUrd) incorporation into DNA of human hematopoietic cells, normal liver and hepatic metastases in man: as a radiosensitizer and as a marker for cell kinetic studies.
    Speth PA; Kinsella TJ; Chang AE; Klecker RW; Belanger K; Smith R; Rowland J; Cupp JE; Collins JM
    Int J Radiat Oncol Biol Phys; 1989 May; 16(5):1247-50. PubMed ID: 2715075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical evaluation of locoregional delivery of radiolabeled iododeoxyuridine and thymidylate synthase inhibitor in a hepatoma model.
    Chi KH; Wang HE; Chen FD; Chao Y; Liu RS; Chou SL; Wang YS; Yen SH
    J Nucl Med; 2001 Feb; 42(2):345-51. PubMed ID: 11216535
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accuracy of histone H3 messenger RNA in situ hybridization for the assessment of cell proliferation in human tissues.
    Kotelnikov V; Cass L; Coon JS; Spaulding D; Preisler HD
    Clin Cancer Res; 1997 May; 3(5):669-73. PubMed ID: 9815735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I clinical and pharmacological study of iododeoxyuridine and bleomycin in patients with advanced cancer.
    Schilsky RL; Janisch L; Berezin F; Mick R; Vogelzang NJ; Ratain MJ
    Cancer Res; 1993 Mar; 53(6):1293-6. PubMed ID: 7680282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continued malignant cell proliferation in head and neck tumors during cytotoxic therapy.
    Preisler HD; Kotelnikov VM; LaFollette S; Taylor S; Mundle S; Wood N; Coon JS; Hutchinson J; Panje W; Caldarelli DD; Griem K
    Clin Cancer Res; 1996 Sep; 2(9):1453-60. PubMed ID: 9816320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interaction of hydroxyurea and iododeoxyuridine on the radiosensitivity of human bladder cancer cells.
    Kuo ML; Kunugi KA; Lindstrom MJ; Kinsella TJ
    Cancer Res; 1995 Jul; 55(13):2800-5. PubMed ID: 7796406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of IdUrd-DNA incorporation and radiosensitization in human bladder carcinoma cells.
    Kunugi KA; Vazquez-Padua MA; Miller EM; Kinsella TJ
    Cancer Res; 1990 Aug; 50(16):4962-7. PubMed ID: 2199032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo modulation of iododeoxyuridine metabolism and incorporation into cellular DNA by 5'-amino-5'-deoxythymidine in normal mouse tissues and two human colon cancer xenografts.
    Kinsella TJ; Glennon MC; Kunugi KA; Lindstrom MJ
    Clin Cancer Res; 1996 Jun; 2(6):981-9. PubMed ID: 9816259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.